Actively Recruiting
Fuzhou Aging Brain Health Initiative Research on Alzheimers Disease Cohorts and Early Diagnosis in Older Adults
Led by Fujian Medical University Union Hospital · Updated on 2026-10-23
3000
Participants Needed
4
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are investigating Alzheimers disease AD in older adults in Fujian Province, China, aiming to understand its development, risk factors, and digital characteristics. This observational study involves establishing cohorts from the general population and those with cognitive impairment to explore genetic influences and develop new diagnostic tools for AD, including plasma biomarkers and PET imaging. Participants will undergo various assessments such as cognitive tests, genetic screening, blood and cerebrospinal fluid sample collections, and advanced brain imaging techniques including MRI and PET scans. The study plans to enroll about 3,000 elderly volunteers and will conduct annual follow-ups to monitor changes over time. Throughout the study, participants will have cognitive and functional assessments using several standardized tools, along with monitoring of biomarkers and neuroimaging changes. Data collection will include digital cognitive testing and electroencephalography. The studys main measurements focus on cognitive function and behavioral changes over an average of one year, with ongoing safety and health monitoring until study completion in 2036.
CONDITIONS
Brief Title
Fuzhou Aging Brain Health Initiative
Research Team
J
Jiawei Xin, MD
J
Jiawei Xin
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here